Clinical Trial Update: Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

View source ↗

Summary

Completed clinical trial evaluating Guardant Health's ctDNA LUNAR test for colorectal cancer screening in an average patient screening episode.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Guardant Health, Inc. | Conditions: Colorectal Cancer | Status: COMPLETED